Trial of improved practices approach to explore the acceptability and feasibility of different modes of chlorhexidine application for neonatal cord care in Pemba, Tanzania

BMC Pregnancy and Childbirth

Volumn 15, Issue 1, 2015, Pages

  Dhingra, Usha ^a,c   Sazawal, Sunil ^a,c   Dhingra, Pratibha ^c   Dutta, Arup ^b   Ali, Said Mohammed ^b   Ame, Shaali Makame ^b   Deb, Saikat ^b   Suleiman, Atifa Mohammed ^b   Black, Robert E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Public Health Laboratory Ivo De Carneri   (Tanzania)

^c Center for Public Health Kinetics   (India)

Author keywords

Chlorhexidine; Cord care; Trials of Improved Practices (TIPs)

Indexed keywords

CHLORHEXIDINE; TOPICAL ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; CULTURAL FACTOR; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; FEMALE; HEALTH AUXILIARY; HEALTH BELIEF; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HEALTH SERVICE; HUMAN; HUMAN EXPERIMENT; METHODOLOGY; MULTICENTER STUDY; NEWBORN; NEWBORN CARE; OMPHALITIS; PATIENT COMPLIANCE; PILOT STUDY; PROGRAM ACCEPTABILITY; PROGRAM FEASIBILITY; QUALITATIVE RESEARCH; RANDOMIZED CONTROLLED TRIAL; TANZANIA; TREATMENT DURATION; TRIALS OF IMPROVED PRACTICES METHOD; UMBILICAL CORD CLEANING; INFANT; INFANT MORTALITY; OBSTETRIC DELIVERY; PATIENT ATTITUDE; PREGNANCY; SEPSIS; UMBILICAL CORD;

ANTI-INFECTIVE AGENTS, LOCAL; CHLORHEXIDINE; DELIVERY, OBSTETRIC; FEMALE; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; PREGNANCY; QUALITATIVE RESEARCH; SEPSIS; TANZANIA; UMBILICAL CORD;

EID: 84951749235     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/s12884-015-0760-4     Document Type: Article

References (29)

1. Lawn JE, Cousens S, Zupan J. Four million neonatal deaths: when? Where? Why? Lancet. 2005;365:891-900.
2. Schuchat A, Ziwicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sulliva MJ, et al. For the PENS study group. Risk factors and opportunities for prevention of early onset neonatal sepsis: a multicentre case control study. Pediatrics. 2000;105:21-6.
3. Lawn JE, Kinney MV, Black RE, Pitt C, Cousens S, Kerber K, et al. Newborn survival: a multi-country analysis of a decade of change. Health Policy Plan. 2012;27 Suppl 3:iii6-iii28.
4. Oestergaard MZ, Inoue M, Yoshida S, Mahanani WR, Gore FM, Cousens S, et al. Neonatal mortality levels for 193 countries in 2009 with trends since 1990: a systemic analysis of progress, projections and priorities. PLoS Med. 2011;8:e1001080.
5. Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating the causes of 4 million neonatal deaths in the year 2000. Int J Epidemiol. 2006;35(3):706-18. Epub 2006 Mar 23.
6. Bryce J, Boschi-Pinto C, Shibuya K, Black RE, WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet. 2005;365:1147-52.
7. World Health Organization. Care of the umbilical cord. WHO/FHE/MSM-cord care. Geneva: WHO; 1998 [Context Link].
8. McClure EM, Goldenberg RL, Brandes N, Darmstadt GL, Wright LL, CHX Working Group et al. The use of chlorhexidine to reduce maternal and neonatal mortality and morbidity in low-resource settings. Int J Gynaecol Obstet. 2007;97:89-94.
9. Goldenberg RL, McClure EM, Saleem S, Rouse D, Vermund S. Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes. Obstet Gynecol. 2006;107:1139-46.
10. Mullany LC, Darmstadt GL, Tielsch JM. Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries. Pediatr Infect Dis J. 2006;25:665-75.
11. Denton GW. Chlorhexidine. In: Block SS, editor. Disinfection, sterilization, and preservation. 5th ed. Philadelphia: Lippincott Williams & Wilkens; 2001. p. 321-6.
12. World Health Organization. WHO Recommendations on Postnatal Care of the Mother and Newborn. 2013. http://apps.who.int/iris/bitstream/10665/93143/1/EMLc_4_eng.pdf.
13. Mullany LC, Darmstadt GL, Khatry SK, Katz J, LeClerg SC, Shrestha S, et al. Topical applications of chlorhexidine to the umbilical cord for prevention of omphalitis and neonatal mortality in southern Nepal: a community-based, cluster-randomised trial. Lancet. 2006;367:910-8.
14. Arifeen SE, Mullany LC, Shah R, Mannan I, Rahman SM, Talukder MR, et al. The effect of cord cleansing with chlorhexidine on neonatal mortality in rural Bangladesh: a community-based, cluster-randomised trial. Lancet. 2012;379(9820):1022-8.
15. Soofi S, Cousens S, Imdad A, Bhutto N, Ali N, Bhutta ZA. Topical application of chlorhexidine to neonatal umbilical cords for prevention of omphalitis and neonatal mortality in a rural district of Pakistan: a community-based, cluster-randomised trial. Lancet. 2012;379(9820):1029-36.
16. Tuladhar S, Ban B. A study on cord-care practices in bardiya district, vol. 52. Kathmandu: Nepal Family Health Program; 2007.
17. Hodgins S, Thapa K, Khanal L, Aryal S, Suvedi BK, Baidya U, et al. Chlorhexidine gel versus aqueous for preventive use on umbilical stump: a randomized noninferiority trial. Pediatr Infect Dis J. 2010;29(11):999-1003.
18. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: n updated systematic analysis for 2010 with time trendssince 2000. Lancet. 2012;379(9832):2151-61. doi: 10.1016/S0140-6736(12)60560-1. Epub 2012 May 11.
19. World Health Organization. Review of the available evidence on 4% chlorhexidine solution for umbilical cord care. Second meeting of the subcommittee of the expert committee on the selection and use of essential medicines. Geneva: WHO; 2008.
20. Zupan J, Garner P, Omari AAA. Topical umbilical cord care at birth. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD001057. doi: 0.1002/14651858.CD001057.pub2.
21. Hyder AA, Wali S, McGuckin J. Burden of disease for neonatal mortality in South Asia and Sub-Saharan Africa. Washington, DC: Save the Children Federation-U.S; 2001. p. 1-93.
22. The Manoff Group. Trials of Improved Practices (TIPs). [homepage on the Internet]. [cited 2015Oct 8]. Available: http://www.manoffgroup.com/resources/summarytips.pdf
23. Dhingra U, Gittelsohn J, Suleiman AM, Suleiman SM, Dutta A, Ali SM, et al. Delivery, immediate newborn and cord care practices in Pemba Tanzania: a qualitative study of community, hospital staff and community level care providers for knowledge, attitudes, belief systems and practices. BMC Pregnancy Childbirth. 2014;14:173.
24. Mullany LC, Faillace S, Tielsch JM, Stolzfus RJ, Nygaard KE, Kavle JA, et al. Incidence and risk factors for newborn umbilical cord infections on Pemba Island, Zanzibar, Tanzania. Pediatr Infect Dis J. 2009;28(6):503-9.
25. Alam MA, Ali NA, Sultana N, Mullany LC, Teela KC, Khan NU, et al. Newborn umbilical cord and skin care in Sylhet District, Bangladesh: implications for the promotion of umbilical cord cleansing with topical chlorhexidine. J Perinatol. 2008;28 Suppl 2:S61-8. doi: 10.1038/jp.2008.164.
26. Mullany LC, Saha SK, Shah R, Islam MS, Rahman M, Islam M, Talukder RR, El Arifeen S, Darmstadt GL, Baqui AH. Impact of 4.0 % Chlorhexidine Cord Cleansing on the Bacteriological Profile of the Newborn Umbilical Stump in Rural Sylhet District, Bangladesh: A Community-Based, Cluster-Randomized Trial. Pediatr Infect Dis J. 2011 Dec 20. [Epub ahead of print].
27. Mullany LC, El Arifeen S, Winch PJ, Shah R, Mannan I, Rahman SM, et al. Impact of 4.0 % chlorhexidine cleansing of the umbilical cord on mortality and omphalitis among newborns of Sylhet, Bangladesh: design of a community-based cluster randomized trial. BMC Pediatr. 2009;9:67.
28. Darmstadt GL, Hossain MM, Choi Y, Shirin M, Mullany LC, Islam M, et al. Safety and effect of chlorhexidine skin cleansing on skin flora of neonates in Bangladesh. Pediatr Infect Dis J. 2007;26:492-5.
29. Mullany LC, Khatry SK, Sherchand JB, LeClerq SC, Darmstadt GL, Katz J, et al. A randomized controlled trial of the impact of chlorhexidine skin cleansing on bacterial colonization of hospital-born infants in Nepal. Pediatr Infect Dis J. 2008;27(6):505-11.